PharmTech News

Jan 02, 2018
By Pharmaceutical Technology Editors
PharMEDium Services, LLC voluntarily recalled some lots of product because of a lack of sterility assurance.
Dec 28, 2017
By Pharmaceutical Technology Editors
Roche has agreed to acquire Ignyta, an oncology company specializing in precision medicines, in an all-cash transaction valued at $1.7 billion.
Dec 28, 2017
By Pharmaceutical Technology Editors
Mallinckrodt has agreed to acquire biopharmaceutical company Sucampo Pharmaceuticals for $18 per share, or a transaction value of approximately $1.2 billion.
Dec 28, 2017
By Pharmaceutical Technology Editors
The recall was initiated due to a product complaint in which white particulate matter, identified as mold, was discovered in a flexible bag from one batch.
Dec 28, 2017
By Pharmaceutical Technology Editors
The biotechnology company has filed for FDA approval of a new plasma manufacturing facility in Covington, GA, to support its immunology franchise.
Dec 28, 2017
By Pharmaceutical Technology Editors
The companies have entered an agreement involving assay development and the manufacturing of kits supporting biomarker research programs.
Dec 20, 2017
By Pharmaceutical Technology Editors
MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.
Dec 20, 2017
By Pharmaceutical Technology Editors
FDA sent a warning letter to Deserving Health International Corp. after inspectors found CGMP violations including failure to prevent microbiological contamination.
Dec 20, 2017
By Pharmaceutical Technology Editors
FDA has approved a new gene therapy for treating patients born with a rare, inherited vision loss.
Dec 20, 2017
By Pharmaceutical Technology Editors
The company is voluntarily recalling one lot of Pantoprazole Sodium for Injection 40 mg per vial because of glass particles found in a vial.
native1_300x100
lorem ipsum